Related references
Note: Only part of the references are listed.Neoadjuvant Therapy in the Post-German Rectal Trial Era: Making Sense in the Absence of Consensus
Caressa Hui et al.
PRACTICAL RADIATION ONCOLOGY (2023)
Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study)
X. Serra-Aracil et al.
ANNALS OF ONCOLOGY (2023)
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer: The future new standard approach?
Luis Cabezon-Gutierrez et al.
EJSO (2023)
Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Keli Wang et al.
JOURNAL OF GASTROINTESTINAL CANCER (2023)
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal Cancer
Hideaki Bando et al.
CLINICAL CANCER RESEARCH (2022)
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas et al.
JAMA ONCOLOGY (2022)
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)
Yaqi Wang et al.
BMC CANCER (2022)
Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative Management
Re- Chin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)
Jing Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer
Gowoon Yang et al.
RADIATION ONCOLOGY (2022)
STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?
Simon Parkinson Bach et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy
Falk Roeder et al.
CANCERS (2022)
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer
Andrea Cercek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons
Trudy C. Wu et al.
CLINICAL COLORECTAL CANCER (2022)
Preliminary Results of a Prospective Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Y. Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Short-Course Radiotherapy Based Total Neoadjuvant Therapy Combined with Toripalimab for Locally Advanced Rectal Cancer: Preliminary Findings from a Randomized, Prospective, Multicenter, Double-Arm, Phase II Trial (TORCH)
Y. Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Rectal Cancer, Version 2.2022
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Peripheral Lymphocyte Counts and Lymphocyte-Related Inflammation Indicators During Radiotherapy for Pelvic Malignancies: Temporal Characterization and Dosimetric Predictors
Xiaoyong Xiang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)
Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
Chun-Kai Liao et al.
CURRENT ONCOLOGY (2022)
The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation
Arthur Affleck et al.
ANNALS OF GASTROENTEROLOGY (2022)
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
Jaume Capdevila et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses
Miao Yu et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)
Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes
N. Hearn et al.
CLINICAL ONCOLOGY (2021)
Single High-Dose Radiation Enhances Dendritic Cell Homing and T Cell Priming by Promoting Reactive Oxygen Species-Induced Cytoskeletal Reorganization
Ziqi Zhou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Watch-and-wait Management for Rectal Cancer After Clinical Complete Response to Neoadjuvant Therapy
Jonathan B. Yuval et al.
Advances in Surgery (2021)
Long-Term Results of a Prospective Phase 2 Study on Volume De-Escalation in Neoadjuvant Chemoradiotherapy of Rectal Cancer
Michele Fiore et al.
PRACTICAL RADIATION ONCOLOGY (2021)
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Jennifer Y. Wo et al.
PRACTICAL RADIATION ONCOLOGY (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer
Incheol Seo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes
Joseph C. Kong et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
Hyun Kim et al.
CLINICAL COLORECTAL CANCER (2021)
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Zhenyu Lin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
Durim Delishaj et al.
WORLD JOURNAL OF CLINICAL CASES (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy
Wei Huang et al.
FRONTIERS IN ONCOLOGY (2021)
Efficacy and safety of neoadjuvant short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma: Averectal study
A. Shamseddine et al.
ANNALS OF ONCOLOGY (2021)
R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radiochemotherapy in a preoperative setting for patients with localized rectal cancer
J. Carrasco et al.
ANNALS OF ONCOLOGY (2021)
Prospective Clinical Investigation of the Efficacy of Combination Radiation Therapy With Immune Checkpoint Inhibition
Elliot H. Akama-Garren et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA study.
Lisa Salvatore et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Catherine R. Hanna et al.
RADIATION ONCOLOGY (2021)
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial
Osama E. Rahma et al.
JAMA ONCOLOGY (2021)
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy
Philippe Lambin et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma
Ali Shamseddine et al.
BMC CANCER (2020)
Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer
Lukasz Kuncman et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma
Ali Shamseddine et al.
RADIATION ONCOLOGY (2020)
A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy
Wonmo Sung et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy
Dawei Chen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
Zachary S. Buchwald et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)
Deborah Schrag et al.
CLINICAL TRIALS (2019)
Long-course preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study
B. Cisel et al.
ANNALS OF ONCOLOGY (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial
Johan Erlandsson et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
Mathieu Grapin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
Yanhong Deng et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
Yong Sang Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immune mechanisms mediating abscopal effects in radioimmunotherapy
Maria E. Rodriguez-Ruiz et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients
C. Yuan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy
Ariel E. Marciscano et al.
CLINICAL CANCER RESEARCH (2018)
A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors
Bhanu Prasad Venkatesulu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience
Arthur Sun Myint et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer
Jian L. Campian et al.
CANCER INVESTIGATION (2018)
Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy
Dengbo Ji et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity
Chan Woo Wee et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States
Yvonne M. Mowery et al.
CANCER (2017)
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
Johan Erlandsson et al.
LANCET ONCOLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Giovanni Germano et al.
NATURE (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
Adam Diehl et al.
ONCOTARGET (2017)
Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?
Jennifer B. Goldstein et al.
CLINICAL CANCER RESEARCH (2017)
Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
Bong Kyung Bae et al.
RADIATION ONCOLOGY JOURNAL (2017)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2017)
Dosimetric predictors of treatment-related lymphopenia induced by palliative radiotherapy: predictive ability of dose-volume parameters based on body surface contour
Tetsuo Saito et al.
RADIOLOGY AND ONCOLOGY (2017)
Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
K. Bujko et al.
ANNALS OF ONCOLOGY (2016)
Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
Angelita Habr-Gama et al.
RADIATION ONCOLOGY (2016)
Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis
Shi-Xin Liu et al.
Asian Pacific Journal of Cancer Prevention (2015)
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
J. Joshua Smith et al.
BMC CANCER (2015)
Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
Anne J. Breugom et al.
LANCET ONCOLOGY (2015)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
A. J. Breugom et al.
ANNALS OF ONCOLOGY (2015)
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi et al.
CANCER RESEARCH (2014)
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
Chad Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost
Ane L. Appelt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Yong Sang Hong et al.
LANCET ONCOLOGY (2014)
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
Jean-Francois Bosset et al.
LANCET ONCOLOGY (2014)
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial
Per J. Nilsson et al.
BMC CANCER (2013)
The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells
Susannah Yovino et al.
CANCER INVESTIGATION (2013)
Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy
Ane L. Appelt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Dosimetric comparison between IMRT delivery modes: Step-and-shoot, sliding window, and volumetric modulated arc therapy - for whole pelvis radiation therapy of intermediate-to-high risk prostate adenocarcinoma
Tania De La Fuente Herman et al.
JOURNAL OF MEDICAL PHYSICS (2013)
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
DISTRIBUTION OF PROLIFERATING BONE MARROW IN ADULT CANCER PATIENTS DETERMINED USING FLT-PET IMAGING
James A. Hayman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
Carlo Aschele et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma
Fei Bao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Youjin Lee et al.
BLOOD (2009)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
ELECTIVE CLINICAL TARGET VOLUMES FOR CONFORMAL THERAPY IN ANORECTAL CANCER: A RADIATION THERAPY ONCOLOGY GROUP CONSENSUS PANEL CONTOURING ATLAS
Robert J. Myerson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
David Sebag-Montefiore et al.
LANCET (2009)
Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy
Steven D. Allen et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Definition and delineation of the clinical target volume for rectal cancer
Sarah Roels et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results
A Habr-Gama et al.
ANNALS OF SURGERY (2004)